0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Rosuvastatin Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-2T658
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Rosuvastatin Market Professional Survey Report 2019
BUY CHAPTERS

Global Rosuvastatin Market Research Report 2025

Code: QYRE-Auto-2T658
Report
January 2025
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Rosuvastatin Market

The global market for Rosuvastatin was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Rosuvastatin medication is a statin that is used to lower bad cholesterol and prevent cardiovascular disease. It works by blocking an enzyme in the liver that makes cholesterol. It is taken by mouth and should be used together with dietary changes, exercise, and weight loss. It may also raise good cholesterol and lower triglycerides. It is sold under the brand name Crestor among others. It may be used when other statins have not worked well.
North American market for Rosuvastatin is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Rosuvastatin is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Rosuvastatin include AstraZeneca, Teva Pharmaceutical Industries, MSN Laboratories, Cadila Pharmaceuticals, LGM Pharma, Bal Pharma, Changzhou Pharmaceutical Factory, Jingxin Pharm, Zhejiang Hisun Pharmaceutical, HEC Pharm, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Rosuvastatin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rosuvastatin.
The Rosuvastatin market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Rosuvastatin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rosuvastatin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Rosuvastatin Market Report

Report Metric Details
Report Name Rosuvastatin Market
Segment by Type
  • Purity 98.0%
  • Purity 99.0%
  • Other
Segment by Application
  • Tablet
  • Capsule
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AstraZeneca, Teva Pharmaceutical Industries, MSN Laboratories, Cadila Pharmaceuticals, LGM Pharma, Bal Pharma, Changzhou Pharmaceutical Factory, Jingxin Pharm, Zhejiang Hisun Pharmaceutical, HEC Pharm, Lunan Pharmaceutical, Nanjing Frochem Tech, Lianyungang Runzhong Pharmaceutical, Shandong Bechem Chemicals, CTX Life Sciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Rosuvastatin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Rosuvastatin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Rosuvastatin Market report?

Ans: The main players in the Rosuvastatin Market are AstraZeneca, Teva Pharmaceutical Industries, MSN Laboratories, Cadila Pharmaceuticals, LGM Pharma, Bal Pharma, Changzhou Pharmaceutical Factory, Jingxin Pharm, Zhejiang Hisun Pharmaceutical, HEC Pharm, Lunan Pharmaceutical, Nanjing Frochem Tech, Lianyungang Runzhong Pharmaceutical, Shandong Bechem Chemicals, CTX Life Sciences

What are the Application segmentation covered in the Rosuvastatin Market report?

Ans: The Applications covered in the Rosuvastatin Market report are Tablet, Capsule, Others

What are the Type segmentation covered in the Rosuvastatin Market report?

Ans: The Types covered in the Rosuvastatin Market report are Purity 98.0%, Purity 99.0%, Other

Recommended Reports

Statin & Lipid Therapy

Cholesterol & Lipid Drugs

Cardiovascular Treatments

1 Rosuvastatin Market Overview
1.1 Product Definition
1.2 Rosuvastatin by Type
1.2.1 Global Rosuvastatin Market Value Comparison by Type (2024 VS 2031)
1.2.2 Purity 98.0%
1.2.3 Purity 99.0%
1.2.4 Other
1.3 Rosuvastatin by Application
1.3.1 Global Rosuvastatin Market Value by Application (2024 VS 2031)
1.3.2 Tablet
1.3.3 Capsule
1.3.4 Others
1.4 Global Rosuvastatin Market Size Estimates and Forecasts
1.4.1 Global Rosuvastatin Revenue 2020-2031
1.4.2 Global Rosuvastatin Sales 2020-2031
1.4.3 Global Rosuvastatin Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Rosuvastatin Market Competition by Manufacturers
2.1 Global Rosuvastatin Sales Market Share by Manufacturers (2020-2025)
2.2 Global Rosuvastatin Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Rosuvastatin Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Rosuvastatin, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Rosuvastatin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Rosuvastatin, Product Type & Application
2.7 Global Key Manufacturers of Rosuvastatin, Date of Enter into This Industry
2.8 Global Rosuvastatin Market Competitive Situation and Trends
2.8.1 Global Rosuvastatin Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Rosuvastatin Players Market Share by Revenue
2.8.3 Global Rosuvastatin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Rosuvastatin Market Scenario by Region
3.1 Global Rosuvastatin Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Rosuvastatin Sales by Region: 2020-2031
3.2.1 Global Rosuvastatin Sales by Region: 2020-2025
3.2.2 Global Rosuvastatin Sales by Region: 2026-2031
3.3 Global Rosuvastatin Revenue by Region: 2020-2031
3.3.1 Global Rosuvastatin Revenue by Region: 2020-2025
3.3.2 Global Rosuvastatin Revenue by Region: 2026-2031
3.4 North America Rosuvastatin Market Facts & Figures by Country
3.4.1 North America Rosuvastatin Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Rosuvastatin Sales by Country (2020-2031)
3.4.3 North America Rosuvastatin Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Rosuvastatin Market Facts & Figures by Country
3.5.1 Europe Rosuvastatin Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Rosuvastatin Sales by Country (2020-2031)
3.5.3 Europe Rosuvastatin Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Rosuvastatin Market Facts & Figures by Region
3.6.1 Asia Pacific Rosuvastatin Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Rosuvastatin Sales by Region (2020-2031)
3.6.3 Asia Pacific Rosuvastatin Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Rosuvastatin Market Facts & Figures by Country
3.7.1 Latin America Rosuvastatin Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Rosuvastatin Sales by Country (2020-2031)
3.7.3 Latin America Rosuvastatin Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Rosuvastatin Market Facts & Figures by Country
3.8.1 Middle East and Africa Rosuvastatin Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Rosuvastatin Sales by Country (2020-2031)
3.8.3 Middle East and Africa Rosuvastatin Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Rosuvastatin Sales by Type (2020-2031)
4.1.1 Global Rosuvastatin Sales by Type (2020-2025)
4.1.2 Global Rosuvastatin Sales by Type (2026-2031)
4.1.3 Global Rosuvastatin Sales Market Share by Type (2020-2031)
4.2 Global Rosuvastatin Revenue by Type (2020-2031)
4.2.1 Global Rosuvastatin Revenue by Type (2020-2025)
4.2.2 Global Rosuvastatin Revenue by Type (2026-2031)
4.2.3 Global Rosuvastatin Revenue Market Share by Type (2020-2031)
4.3 Global Rosuvastatin Price by Type (2020-2031)
5 Segment by Application
5.1 Global Rosuvastatin Sales by Application (2020-2031)
5.1.1 Global Rosuvastatin Sales by Application (2020-2025)
5.1.2 Global Rosuvastatin Sales by Application (2026-2031)
5.1.3 Global Rosuvastatin Sales Market Share by Application (2020-2031)
5.2 Global Rosuvastatin Revenue by Application (2020-2031)
5.2.1 Global Rosuvastatin Revenue by Application (2020-2025)
5.2.2 Global Rosuvastatin Revenue by Application (2026-2031)
5.2.3 Global Rosuvastatin Revenue Market Share by Application (2020-2031)
5.3 Global Rosuvastatin Price by Application (2020-2031)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Company Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Rosuvastatin Sales, Revenue and Gross Margin (2020-2025)
6.1.4 AstraZeneca Rosuvastatin Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Teva Pharmaceutical Industries
6.2.1 Teva Pharmaceutical Industries Company Information
6.2.2 Teva Pharmaceutical Industries Description and Business Overview
6.2.3 Teva Pharmaceutical Industries Rosuvastatin Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Teva Pharmaceutical Industries Rosuvastatin Product Portfolio
6.2.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.3 MSN Laboratories
6.3.1 MSN Laboratories Company Information
6.3.2 MSN Laboratories Description and Business Overview
6.3.3 MSN Laboratories Rosuvastatin Sales, Revenue and Gross Margin (2020-2025)
6.3.4 MSN Laboratories Rosuvastatin Product Portfolio
6.3.5 MSN Laboratories Recent Developments/Updates
6.4 Cadila Pharmaceuticals
6.4.1 Cadila Pharmaceuticals Company Information
6.4.2 Cadila Pharmaceuticals Description and Business Overview
6.4.3 Cadila Pharmaceuticals Rosuvastatin Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Cadila Pharmaceuticals Rosuvastatin Product Portfolio
6.4.5 Cadila Pharmaceuticals Recent Developments/Updates
6.5 LGM Pharma
6.5.1 LGM Pharma Company Information
6.5.2 LGM Pharma Description and Business Overview
6.5.3 LGM Pharma Rosuvastatin Sales, Revenue and Gross Margin (2020-2025)
6.5.4 LGM Pharma Rosuvastatin Product Portfolio
6.5.5 LGM Pharma Recent Developments/Updates
6.6 Bal Pharma
6.6.1 Bal Pharma Company Information
6.6.2 Bal Pharma Description and Business Overview
6.6.3 Bal Pharma Rosuvastatin Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Bal Pharma Rosuvastatin Product Portfolio
6.6.5 Bal Pharma Recent Developments/Updates
6.7 Changzhou Pharmaceutical Factory
6.7.1 Changzhou Pharmaceutical Factory Company Information
6.7.2 Changzhou Pharmaceutical Factory Description and Business Overview
6.7.3 Changzhou Pharmaceutical Factory Rosuvastatin Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Changzhou Pharmaceutical Factory Rosuvastatin Product Portfolio
6.7.5 Changzhou Pharmaceutical Factory Recent Developments/Updates
6.8 Jingxin Pharm
6.8.1 Jingxin Pharm Company Information
6.8.2 Jingxin Pharm Description and Business Overview
6.8.3 Jingxin Pharm Rosuvastatin Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Jingxin Pharm Rosuvastatin Product Portfolio
6.8.5 Jingxin Pharm Recent Developments/Updates
6.9 Zhejiang Hisun Pharmaceutical
6.9.1 Zhejiang Hisun Pharmaceutical Company Information
6.9.2 Zhejiang Hisun Pharmaceutical Description and Business Overview
6.9.3 Zhejiang Hisun Pharmaceutical Rosuvastatin Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Zhejiang Hisun Pharmaceutical Rosuvastatin Product Portfolio
6.9.5 Zhejiang Hisun Pharmaceutical Recent Developments/Updates
6.10 HEC Pharm
6.10.1 HEC Pharm Company Information
6.10.2 HEC Pharm Description and Business Overview
6.10.3 HEC Pharm Rosuvastatin Sales, Revenue and Gross Margin (2020-2025)
6.10.4 HEC Pharm Rosuvastatin Product Portfolio
6.10.5 HEC Pharm Recent Developments/Updates
6.11 Lunan Pharmaceutical
6.11.1 Lunan Pharmaceutical Company Information
6.11.2 Lunan Pharmaceutical Description and Business Overview
6.11.3 Lunan Pharmaceutical Rosuvastatin Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Lunan Pharmaceutical Rosuvastatin Product Portfolio
6.11.5 Lunan Pharmaceutical Recent Developments/Updates
6.12 Nanjing Frochem Tech
6.12.1 Nanjing Frochem Tech Company Information
6.12.2 Nanjing Frochem Tech Description and Business Overview
6.12.3 Nanjing Frochem Tech Rosuvastatin Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Nanjing Frochem Tech Rosuvastatin Product Portfolio
6.12.5 Nanjing Frochem Tech Recent Developments/Updates
6.13 Lianyungang Runzhong Pharmaceutical
6.13.1 Lianyungang Runzhong Pharmaceutical Company Information
6.13.2 Lianyungang Runzhong Pharmaceutical Description and Business Overview
6.13.3 Lianyungang Runzhong Pharmaceutical Rosuvastatin Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Lianyungang Runzhong Pharmaceutical Rosuvastatin Product Portfolio
6.13.5 Lianyungang Runzhong Pharmaceutical Recent Developments/Updates
6.14 Shandong Bechem Chemicals
6.14.1 Shandong Bechem Chemicals Company Information
6.14.2 Shandong Bechem Chemicals Description and Business Overview
6.14.3 Shandong Bechem Chemicals Rosuvastatin Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Shandong Bechem Chemicals Rosuvastatin Product Portfolio
6.14.5 Shandong Bechem Chemicals Recent Developments/Updates
6.15 CTX Life Sciences
6.15.1 CTX Life Sciences Company Information
6.15.2 CTX Life Sciences Description and Business Overview
6.15.3 CTX Life Sciences Rosuvastatin Sales, Revenue and Gross Margin (2020-2025)
6.15.4 CTX Life Sciences Rosuvastatin Product Portfolio
6.15.5 CTX Life Sciences Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Rosuvastatin Industry Chain Analysis
7.2 Rosuvastatin Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Rosuvastatin Production Mode & Process Analysis
7.4 Rosuvastatin Sales and Marketing
7.4.1 Rosuvastatin Sales Channels
7.4.2 Rosuvastatin Distributors
7.5 Rosuvastatin Customer Analysis
8 Rosuvastatin Market Dynamics
8.1 Rosuvastatin Industry Trends
8.2 Rosuvastatin Market Drivers
8.3 Rosuvastatin Market Challenges
8.4 Rosuvastatin Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Rosuvastatin Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Rosuvastatin Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Rosuvastatin Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Rosuvastatin Sales (K MT) of Key Manufacturers (2020-2025)
 Table 5. Global Rosuvastatin Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Rosuvastatin Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Rosuvastatin Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Rosuvastatin Average Price (USD/MT) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Rosuvastatin, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Rosuvastatin, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Rosuvastatin, Product Type & Application
 Table 12. Global Key Manufacturers of Rosuvastatin, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Rosuvastatin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rosuvastatin as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Rosuvastatin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Rosuvastatin Sales by Region (2020-2025) & (K MT)
 Table 18. Global Rosuvastatin Sales Market Share by Region (2020-2025)
 Table 19. Global Rosuvastatin Sales by Region (2026-2031) & (K MT)
 Table 20. Global Rosuvastatin Sales Market Share by Region (2026-2031)
 Table 21. Global Rosuvastatin Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Rosuvastatin Revenue Market Share by Region (2020-2025)
 Table 23. Global Rosuvastatin Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Rosuvastatin Revenue Market Share by Region (2026-2031)
 Table 25. North America Rosuvastatin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Rosuvastatin Sales by Country (2020-2025) & (K MT)
 Table 27. North America Rosuvastatin Sales by Country (2026-2031) & (K MT)
 Table 28. North America Rosuvastatin Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Rosuvastatin Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Rosuvastatin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Rosuvastatin Sales by Country (2020-2025) & (K MT)
 Table 32. Europe Rosuvastatin Sales by Country (2026-2031) & (K MT)
 Table 33. Europe Rosuvastatin Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Rosuvastatin Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Rosuvastatin Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Rosuvastatin Sales by Region (2020-2025) & (K MT)
 Table 37. Asia Pacific Rosuvastatin Sales by Region (2026-2031) & (K MT)
 Table 38. Asia Pacific Rosuvastatin Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Rosuvastatin Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Rosuvastatin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Rosuvastatin Sales by Country (2020-2025) & (K MT)
 Table 42. Latin America Rosuvastatin Sales by Country (2026-2031) & (K MT)
 Table 43. Latin America Rosuvastatin Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Rosuvastatin Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Rosuvastatin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Rosuvastatin Sales by Country (2020-2025) & (K MT)
 Table 47. Middle East and Africa Rosuvastatin Sales by Country (2026-2031) & (K MT)
 Table 48. Middle East and Africa Rosuvastatin Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Rosuvastatin Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Rosuvastatin Sales (K MT) by Type (2020-2025)
 Table 51. Global Rosuvastatin Sales (K MT) by Type (2026-2031)
 Table 52. Global Rosuvastatin Sales Market Share by Type (2020-2025)
 Table 53. Global Rosuvastatin Sales Market Share by Type (2026-2031)
 Table 54. Global Rosuvastatin Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Rosuvastatin Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Rosuvastatin Revenue Market Share by Type (2020-2025)
 Table 57. Global Rosuvastatin Revenue Market Share by Type (2026-2031)
 Table 58. Global Rosuvastatin Price (USD/MT) by Type (2020-2025)
 Table 59. Global Rosuvastatin Price (USD/MT) by Type (2026-2031)
 Table 60. Global Rosuvastatin Sales (K MT) by Application (2020-2025)
 Table 61. Global Rosuvastatin Sales (K MT) by Application (2026-2031)
 Table 62. Global Rosuvastatin Sales Market Share by Application (2020-2025)
 Table 63. Global Rosuvastatin Sales Market Share by Application (2026-2031)
 Table 64. Global Rosuvastatin Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Rosuvastatin Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Rosuvastatin Revenue Market Share by Application (2020-2025)
 Table 67. Global Rosuvastatin Revenue Market Share by Application (2026-2031)
 Table 68. Global Rosuvastatin Price (USD/MT) by Application (2020-2025)
 Table 69. Global Rosuvastatin Price (USD/MT) by Application (2026-2031)
 Table 70. AstraZeneca Company Information
 Table 71. AstraZeneca Description and Business Overview
 Table 72. AstraZeneca Rosuvastatin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 73. AstraZeneca Rosuvastatin Product
 Table 74. AstraZeneca Recent Developments/Updates
 Table 75. Teva Pharmaceutical Industries Company Information
 Table 76. Teva Pharmaceutical Industries Description and Business Overview
 Table 77. Teva Pharmaceutical Industries Rosuvastatin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 78. Teva Pharmaceutical Industries Rosuvastatin Product
 Table 79. Teva Pharmaceutical Industries Recent Developments/Updates
 Table 80. MSN Laboratories Company Information
 Table 81. MSN Laboratories Description and Business Overview
 Table 82. MSN Laboratories Rosuvastatin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 83. MSN Laboratories Rosuvastatin Product
 Table 84. MSN Laboratories Recent Developments/Updates
 Table 85. Cadila Pharmaceuticals Company Information
 Table 86. Cadila Pharmaceuticals Description and Business Overview
 Table 87. Cadila Pharmaceuticals Rosuvastatin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 88. Cadila Pharmaceuticals Rosuvastatin Product
 Table 89. Cadila Pharmaceuticals Recent Developments/Updates
 Table 90. LGM Pharma Company Information
 Table 91. LGM Pharma Description and Business Overview
 Table 92. LGM Pharma Rosuvastatin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 93. LGM Pharma Rosuvastatin Product
 Table 94. LGM Pharma Recent Developments/Updates
 Table 95. Bal Pharma Company Information
 Table 96. Bal Pharma Description and Business Overview
 Table 97. Bal Pharma Rosuvastatin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 98. Bal Pharma Rosuvastatin Product
 Table 99. Bal Pharma Recent Developments/Updates
 Table 100. Changzhou Pharmaceutical Factory Company Information
 Table 101. Changzhou Pharmaceutical Factory Description and Business Overview
 Table 102. Changzhou Pharmaceutical Factory Rosuvastatin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 103. Changzhou Pharmaceutical Factory Rosuvastatin Product
 Table 104. Changzhou Pharmaceutical Factory Recent Developments/Updates
 Table 105. Jingxin Pharm Company Information
 Table 106. Jingxin Pharm Description and Business Overview
 Table 107. Jingxin Pharm Rosuvastatin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 108. Jingxin Pharm Rosuvastatin Product
 Table 109. Jingxin Pharm Recent Developments/Updates
 Table 110. Zhejiang Hisun Pharmaceutical Company Information
 Table 111. Zhejiang Hisun Pharmaceutical Description and Business Overview
 Table 112. Zhejiang Hisun Pharmaceutical Rosuvastatin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 113. Zhejiang Hisun Pharmaceutical Rosuvastatin Product
 Table 114. Zhejiang Hisun Pharmaceutical Recent Developments/Updates
 Table 115. HEC Pharm Company Information
 Table 116. HEC Pharm Description and Business Overview
 Table 117. HEC Pharm Rosuvastatin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 118. HEC Pharm Rosuvastatin Product
 Table 119. HEC Pharm Recent Developments/Updates
 Table 120. Lunan Pharmaceutical Company Information
 Table 121. Lunan Pharmaceutical Description and Business Overview
 Table 122. Lunan Pharmaceutical Rosuvastatin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 123. Lunan Pharmaceutical Rosuvastatin Product
 Table 124. Lunan Pharmaceutical Recent Developments/Updates
 Table 125. Nanjing Frochem Tech Company Information
 Table 126. Nanjing Frochem Tech Description and Business Overview
 Table 127. Nanjing Frochem Tech Rosuvastatin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 128. Nanjing Frochem Tech Rosuvastatin Product
 Table 129. Nanjing Frochem Tech Recent Developments/Updates
 Table 130. Lianyungang Runzhong Pharmaceutical Company Information
 Table 131. Lianyungang Runzhong Pharmaceutical Description and Business Overview
 Table 132. Lianyungang Runzhong Pharmaceutical Rosuvastatin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 133. Lianyungang Runzhong Pharmaceutical Rosuvastatin Product
 Table 134. Lianyungang Runzhong Pharmaceutical Recent Developments/Updates
 Table 135. Shandong Bechem Chemicals Company Information
 Table 136. Shandong Bechem Chemicals Description and Business Overview
 Table 137. Shandong Bechem Chemicals Rosuvastatin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 138. Shandong Bechem Chemicals Rosuvastatin Product
 Table 139. Shandong Bechem Chemicals Recent Developments/Updates
 Table 140. CTX Life Sciences Company Information
 Table 141. CTX Life Sciences Description and Business Overview
 Table 142. CTX Life Sciences Rosuvastatin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 143. CTX Life Sciences Rosuvastatin Product
 Table 144. CTX Life Sciences Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Rosuvastatin Distributors List
 Table 148. Rosuvastatin Customers List
 Table 149. Rosuvastatin Market Trends
 Table 150. Rosuvastatin Market Drivers
 Table 151. Rosuvastatin Market Challenges
 Table 152. Rosuvastatin Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Rosuvastatin
 Figure 2. Global Rosuvastatin Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Rosuvastatin Market Share by Type: 2024 & 2031
 Figure 4. Purity 98.0% Product Picture
 Figure 5. Purity 99.0% Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global Rosuvastatin Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Rosuvastatin Market Share by Application: 2024 & 2031
 Figure 9. Tablet
 Figure 10. Capsule
 Figure 11. Others
 Figure 12. Global Rosuvastatin Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Rosuvastatin Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Rosuvastatin Sales (2020-2031) & (K MT)
 Figure 15. Global Rosuvastatin Average Price (USD/MT) & (2020-2031)
 Figure 16. Rosuvastatin Report Years Considered
 Figure 17. Rosuvastatin Sales Share by Manufacturers in 2024
 Figure 18. Global Rosuvastatin Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Rosuvastatin Players: Market Share by Revenue in Rosuvastatin in 2024
 Figure 20. Rosuvastatin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Rosuvastatin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Rosuvastatin Sales Market Share by Country (2020-2031)
 Figure 23. North America Rosuvastatin Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. Rosuvastatin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Rosuvastatin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Rosuvastatin Sales Market Share by Country (2020-2031)
 Figure 27. Europe Rosuvastatin Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Rosuvastatin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Rosuvastatin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Rosuvastatin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Rosuvastatin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Rosuvastatin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Rosuvastatin Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Rosuvastatin Revenue Market Share by Region (2020-2031)
 Figure 35. China Rosuvastatin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Rosuvastatin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Rosuvastatin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Rosuvastatin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Rosuvastatin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan Rosuvastatin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Rosuvastatin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Rosuvastatin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Rosuvastatin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines Rosuvastatin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Rosuvastatin Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Rosuvastatin Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Rosuvastatin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Rosuvastatin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Rosuvastatin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Rosuvastatin Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Rosuvastatin Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Rosuvastatin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Rosuvastatin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. U.A.E Rosuvastatin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Rosuvastatin by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Rosuvastatin by Type (2020-2031)
 Figure 57. Global Rosuvastatin Price (USD/MT) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Rosuvastatin by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Rosuvastatin by Application (2020-2031)
 Figure 60. Global Rosuvastatin Price (USD/MT) by Application (2020-2031)
 Figure 61. Rosuvastatin Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network